美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Sanofi

93.60

+0.62200.67%

成交量：10.08萬

成交額：931.02萬

市值：1,141.45億

市盈率：17.17

高：93.76

開：92.98

低：92.98

收：92.98

52周最高：122.03

52周最低：90.05

股本：12.19億

流通股本：10.98億

量比：0.60

換手率：0.01%

股息：4.70

股息率：5.02%

每股收益(TTM):5.45

每股收益(LYR):4.60

淨資產收益率：6.66%

總資產收益率：4.56%

市淨率：1.35

市盈率(LYR):20.35

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

美國OTC市場Sanofi盤中異動早盤股價大跌3.19%

獨家：輝瑞、賽諾菲、葛蘭素史克、諾華與勃林格殷格翰等藥企提價均與特朗普政府簽有定價協議

ADEL與賽諾菲簽署了一項價值10.4億美元的全球許可協議，涉及新型阿爾茨海默病研究性療法ADEL-Y01ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy

美國OTC市場Sanofi漲2.32% 股價突破100美元大關

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SNYNF"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNYNF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNYNF\",,,,,undefined,":{"symbol":"SNYNF","market":"US","secType":"STK","nameCN":"Sanofi","latestPrice":93.602,"timestamp":1771360920000,"preClose":92.98,"halted":0,"volume":100781,"delay":15,"changeRate":0.006689610668961066,"floatShares":1098441430,"shares":1219473844,"eps":5.452053,"marketStatus":"交易中","change":0.622,"latestTime":"02-17 15:42:00 EST 延時","open":92.98,"high":93.76,"low":92.98,"amount":9310170.95182,"amplitude":0.008389,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":5.452053,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1771362000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":92.98,"volumeRatio":0.603188},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNYNF\",,,,,undefined,":{"symbol":"SNYNF","floatShares":1098441430,"roa":"4.56%","roe":"6.66%","lyrEps":4.599879,"volumeRatio":0.603188,"shares":1219473844,"dividePrice":4.695718,"high":93.76,"amplitude":0.008389,"preClose":92.98,"low":92.98,"week52Low":90.05,"pbRate":"1.35","psRate":"2.06","week52High":122.028,"institutionHeld":0,"latestPrice":93.602,"eps":5.452053,"divideRate":0.050167,"volume":100781,"delay":15,"ttmEps":5.452053,"open":92.98,"prevYearClose":97.295,"prevWeekClose":92.98,"prevMonthClose":91.11,"prevQuarterClose":97.295,"fiveDayClose":95.32,"twentyDayClose":92.198,"sixtyDayClose":98.78},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNYNF\",params:#limit:5,,,undefined,":[{"date":"2025-05-12","symbol":"SNYNF","amount":3.92,"announcedDate":"2025-01-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-13","defaultRemindTime":1747056600000,"name":"Sanofi","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-14","payableDate":"2025-05-13","currency":"EUR","dateTimestamp":1747022400000,"payDate":"2025-05-14"},{"date":"2024-05-13","symbol":"SNYNF","amount":3.76,"announcedDate":"2024-02-01","type":"dividend","market":"US","newRecordDate":"2024-05-14","defaultRemindTime":1715607000000,"name":"Sanofi","recordDate":"2024-05-15","payableDate":"2024-05-14","currency":"EUR","dateTimestamp":1715572800000,"payDate":"2024-05-15"},{"market":"US","date":"2024-04-25","symbol":"SNYNF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"pre","actualEps":null},{"date":"2023-05-30","symbol":"SNYNF","amount":3.56,"announcedDate":"2023-02-03","type":"dividend","market":"US","newRecordDate":"2023-05-31","defaultRemindTime":1685453400000,"name":"Sanofi","recordDate":"2023-06-01","payableDate":"2023-05-31","currency":"EUR","dateTimestamp":1685419200000,"payDate":"2023-06-01"},{"date":"2022-10-28","symbol":"SNYNF","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1666944000000,"name":null,"time":"盤前","dateTimestamp":1666929600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNYNF\",market:\"US\",,,undefined,":[{"executeDate":"2019-05-09","recordDate":"2019-05-10","paymentDate":"2019-05-13","value":3.07,"currency":"EUR"},{"executeDate":"2020-05-04","recordDate":"2020-05-05","paymentDate":"2020-05-06","value":3.15,"currency":"EUR"},{"executeDate":"2021-05-05","recordDate":"2021-05-06","paymentDate":"2021-05-07","value":3.2,"currency":"EUR"},{"executeDate":"2022-05-06","recordDate":"2022-05-09","paymentDate":"2022-05-10","value":3.33,"currency":"EUR"},{"executeDate":"2023-05-30","recordDate":"2023-05-31","paymentDate":"2023-06-01","value":3.56,"currency":"EUR"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNYNF\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNYNF\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2600096814","title":"美國OTC市場Sanofi盤中異動 早盤股價大跌3.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600096814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600096814?lang=zh_tw&edition=fundamental","pubTime":"2026-01-02 22:46","pubTimestamp":1767365195,"startTime":"0","endTime":"0","summary":"北京时间2026年01月02日22时46分，美国OTC市场Sanofi股票出现波动，股价急速跳水3.19%。截至发稿，该股报94.19美元/股，成交量300股，换手率0.00%，振幅0.00%。美国OTC市场Sanofi股票所在的制药行业中，整体跌幅为0.90%。美国OTC市场Sanofi公司简介：赛诺菲专注于免疫学、疫苗和罕见病领域的药物开发和销售。总收入的约 45% 来自美国，20% 来自欧洲，6% 来自中国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102224635a6ebf0c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102224635a6ebf0c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SNYNF","GCVRZ"],"gpt_icon":0},{"id":"1142483575","title":"獨家：輝瑞、賽諾菲、葛蘭素史克、諾華與勃林格殷格翰等藥企提價 均與特朗普政府簽有定價協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1142483575","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142483575?lang=zh_tw&edition=fundamental","pubTime":"2025-12-31 19:01","pubTimestamp":1767178892,"startTime":"0","endTime":"0","summary":"据独家消息披露，包括辉瑞(Pfizer)、赛诺菲(Sanofi)、葛兰素史克(GSK)、诺华(Novartis)及勃林格殷格翰(Boehringer Ingelheim)在内的多家跨国制药巨头近期上调了药品价格。值得注意的是，这些企业此前均与美国特朗普政府达成了药品定价相关协议。\n此次调价涉及多款处方药与疫苗产品，引发市场对医疗成本上升的担忧。尽管制药企业声称提价主要源于研发投入增加与通胀压力，但消费者权益组织批评此举将加剧患者用药负担。\n行业分析师指出，在政府定价协议框架下仍执行涨价策略，反映出药企在政策约束与利润追求间的复杂博弈。未来药品定价监管趋势与药企战略调整将成为行业关注焦点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046248800.SGD","LU1645745479.HKD","BK4550","LU0225284248.USD","LU1400636491.USD","LU1066053197.SGD","LU1400636657.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU0456855351.SGD","IE00BQJZX424.USD","BK4533","LU0575583348.USD","SNYNF","LU0306806265.USD","LU0203347892.USD","LU1202635105.USD","SG9999002224.SGD","LU0122379950.USD","BK4581","LU1228905540.USD","LU0170899867.USD","BK4592","LU0321505439.SGD","BK4007","SGXZ57979304.SGD","IE00BWDBJ516.SGD","LU1015430645.USD","SG9999013999.USD","SG9999001176.USD","LU0161305163.EUR","BK4585","LU0211331839.USD","LU1023059063.AUD","IE00BLSP4452.SGD","LU1481599808.USD","GSK","BK4568","IE00B19Z3B42.SGD","LU0545562505.USD","LU1228905037.USD","LU1302929846.USD","LU1670756490.USD","IE00B3T34201.USD","LU0306807586.USD","LU1481600234.SGD","LU0109981661.USD","SG9999003800.SGD","IE000M9KFDE8.USD","LU0234572021.USD","SG9999001176.SGD","IE00B19Z3581.USD","LU0985481810.HKD","LU0971552830.HKD","SG9999011175.SGD","BK4534","LU0203345920.USD","LU0058720904.USD","NVS","LU1066051498.USD","BK4599","LU1400636574.HKD","LU1883839398.USD","LU0225771236.USD","LU1894683264.USD","BK5011","IE00BBT3K403.USD","LU1894683348.USD","SG9999002232.USD","LU0971552673.USD","IE0034235071.USD","LU0321505868.SGD","LU1057294990.SGD","LU1487256676.USD","IE0002270589.USD","BK4588","LU1098665638.USD","PFE","LU1064927863.SGD","LU1309081286.SGD","LU0868494617.USD","LU1035777561.USD"],"gpt_icon":0},{"id":"2592514799","title":"ADEL與賽諾菲簽署了一項價值10.4億美元的全球許可協議，涉及新型阿爾茨海默病研究性療法ADEL-Y01ADEL Signs $1.04 Billion Global License Agreement with Sanofi for ADEL-Y01, a Novel investigational Alzheimer's Disease Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2592514799","media":"动脉网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592514799?lang=zh_tw&edition=fundamental","pubTime":"2025-12-16 14:41","pubTimestamp":1765867260,"startTime":"0","endTime":"0","summary":"The total potential value of the agreement is up to $1.04 billion. ADEL will receive a non-refundable upfront payment of $80 million and is eligible to receive additional payments contingent upon the achievement of specified development and commercial milestones. Additionally, ADEL is entitled to receive tiered royalties on net sales ranging up to double-digit percentages..协议的总潜在价值高达 10.4 亿美元。ADEL spearheaded the entire discovery and preclinical development of ADEL-Y01 using its proprietary neural disease research and development platform. Since 2020, ADEL has been co-developing the asset through a joint research and development agreement with Oscotec Inc. Currently, ADEL-Y01 is undergoing a global Phase 1 clinical trial  under an Investigational New Drug  application approved by the U.S.ADEL利用其专有的神经疾病研发平台，引领了ADEL-Y01的整个发现和临床前开发过程。自2020年起，ADEL通过与Oscotec Inc.签订的联合研发协议共同开发该资产。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216144226a6a844ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216144226a6a844ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GCVRZ","SNYNF"],"gpt_icon":0},{"id":"2586040284","title":"美國OTC市場Sanofi漲2.32% 股價突破100美元大關","url":"https://stock-news.laohu8.com/highlight/detail?id=2586040284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586040284?lang=zh_tw&edition=fundamental","pubTime":"2025-11-26 04:32","pubTimestamp":1764102742,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日04时32分，美国OTC市场Sanofi股票出现异动，股价急速拉升2.32%。截至发稿，该股报100.00美元/股，成交量3.8644万股，换手率0.00%，振幅0.00%。美国OTC市场Sanofi股票所在的制药行业中，整体涨幅为2.81%。美国OTC市场Sanofi公司简介：赛诺菲专注于免疫学、疫苗和罕见病领域的药物开发和销售。总收入的约 45% 来自美国，20% 来自欧洲，6% 来自中国。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126043223951a28d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126043223951a28d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SNYNF","GCVRZ"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SNYNF\",params:#limit:6,delay:false,,,undefined,":[]}}